CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,954 | +22.1% | 2,190 | +86.2% | 0.00% | – |
| Q2 2023 | $12,248 | +52.6% | 1,176 | +2.0% | 0.00% | – |
| Q1 2023 | $8,028 | +14.7% | 1,153 | -4.9% | 0.00% | – |
| Q4 2022 | $7,000 | -36.4% | 1,213 | -10.0% | 0.00% | – |
| Q3 2022 | $11,000 | -42.1% | 1,348 | -6.9% | 0.00% | – |
| Q2 2022 | $19,000 | -40.6% | 1,448 | -11.0% | 0.00% | – |
| Q1 2022 | $32,000 | -38.5% | 1,627 | +3.6% | 0.00% | – |
| Q4 2021 | $52,000 | -50.0% | 1,570 | -17.4% | 0.00% | – |
| Q3 2021 | $104,000 | +36.8% | 1,900 | +82.7% | 0.00% | – |
| Q2 2021 | $76,000 | -24.0% | 1,040 | -5.2% | 0.00% | – |
| Q1 2021 | $100,000 | +127.3% | 1,097 | +100.9% | 0.00% | – |
| Q4 2020 | $44,000 | -2.2% | 546 | -44.1% | 0.00% | – |
| Q3 2020 | $45,000 | – | 976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |